Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Holding ALGS?
Track your performance easily

Aligos Therapeutics (ALGS) Financial Statements

106 Followers

Aligos Therapeutics Financial Overview

Aligos Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aligos Therapeutics is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $-26.52. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.06M$ 694.00K$ 2.68M$ 1.08M$ 4.29M
Gross Profit$ 1.06M$ 694.00K$ 672.00K$ 1.08M$ 4.29M
EBIT$ -26.41M$ -35.44M$ -26.00M$ -18.01M$ -18.03M
EBITDA$ -25.80M$ -34.83M$ -25.22M$ -17.34M$ -17.43M
Net Income Common Stockholders$ 5.06M$ -34.86M$ -27.89M$ -18.04M$ -18.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 94.54M$ 112.74M$ 135.70M$ 70.43M$ 90.88M
Total Assets$ 108.81M$ 127.90M$ 151.53M$ 85.85M$ 106.13M
Total Debt$ 9.84M$ 10.48M$ 11.14M$ 11.77M$ 12.41M
Net Debt$ -84.70M$ -102.25M$ -124.57M$ -58.66M$ -78.47M
Total Liabilities$ 41.58M$ 68.11M$ 59.45M$ 31.03M$ 36.49M
Stockholders Equity$ 67.23M$ 59.80M$ 92.08M$ 54.82M$ 69.59M
Cash Flow-
Free Cash Flow$ -19.49M$ -22.75M$ -22.68M$ -20.38M$ -13.61M
Operating Cash Flow$ -19.49M$ -22.75M$ -22.66M$ -20.38M$ -13.62M
Investing Cash Flow$ 39.99M$ -88.64M$ -7.00K$ -9.00K$ 25.00M
Financing Cash Flow$ 281.00K$ -19.00K$ 87.94M$ -21.00K$ 414.00K
Currency in USD

Aligos Therapeutics Earnings and Revenue History

Aligos Therapeutics Debt to Assets

Aligos Therapeutics Cash Flow

Aligos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis